KR830008675A - 항소화성 궤양제의 제조방법 - Google Patents
항소화성 궤양제의 제조방법 Download PDFInfo
- Publication number
- KR830008675A KR830008675A KR1019820000033A KR820000033A KR830008675A KR 830008675 A KR830008675 A KR 830008675A KR 1019820000033 A KR1019820000033 A KR 1019820000033A KR 820000033 A KR820000033 A KR 820000033A KR 830008675 A KR830008675 A KR 830008675A
- Authority
- KR
- South Korea
- Prior art keywords
- producing
- ulcer
- dosage form
- extinguishing
- benzoic acid
- Prior art date
Links
- 208000025865 Ulcer Diseases 0.000 title claims 6
- 231100000397 ulcer Toxicity 0.000 title claims 6
- 238000000034 method Methods 0.000 title claims 3
- 238000004519 manufacturing process Methods 0.000 claims 5
- 239000002552 dosage form Substances 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- -1 amino benzoic acid compound Chemical class 0.000 claims 2
- 229960004050 aminobenzoic acid Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000005415 aminobenzoic acids Chemical class 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 일반식(R1,R2및 R3은 동일 또는 상이한 수소원자, 할로겐원자, 저급알킬기 또는 저급 알콕시기를 뜻한다. 단R1=R2=R3=H을 제외한다)로 나타내는 아미노 안식향산 화합물 또는 그 염을 유효성분으로 하는 항서화성 궤양제의 제조방법.
- 제1항에 있어 제형이 정제, 과립제, 산제, 캅셀제 등의 경구용 제형인 항소화성 궤양제의 제조방법.
- 제2항에 있어 담체가 유당, 전분, 덱스트린, 만니톨, 백당, 결정 셀루로즈, 탄산칼슘, 탈크, 스테아린산 마그네슘등인 항소화성 궤양제의 제조방법.
- 제2항에 있어 1투여 단위당의 아미노 안식향산화합물 또는 그 염의 함유량이 250―750㎎인 항소화성 궤양제의 제조방법.
- 제1항에 있어 제형이 주상요 제형인 항소화성 궤양제의 제조방법.
- 제5항에 있어 담체가 증류수, 염화나트륨 용액 또는 염화칼륨 용액등인 항소화성 궤양제의 제조방법.
- 제5항에 있어 1투여 단위당의 아미노 안식향산 화합물 또는 그 염의 함유량이 50∼150㎎인 항소화성 궤양제의 제조방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019820000033A KR830008675A (ko) | 1982-01-06 | 1982-01-06 | 항소화성 궤양제의 제조방법 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019820000033A KR830008675A (ko) | 1982-01-06 | 1982-01-06 | 항소화성 궤양제의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR830008675A true KR830008675A (ko) | 1983-12-14 |
Family
ID=55025478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019820000033A KR830008675A (ko) | 1982-01-06 | 1982-01-06 | 항소화성 궤양제의 제조방법 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR830008675A (ko) |
-
1982
- 1982-01-06 KR KR1019820000033A patent/KR830008675A/ko unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR840008014A (ko) | 오메프라졸염의 제조방법 | |
| KR890700590A (ko) | 폴린산의 분리방법 | |
| SE8702705D0 (sv) | Kristallint cefalosporinderivat | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| RU94028888A (ru) | Производные 1,3-замещенного циклоалкана и циклоалкена, смесь их изомеров или индивидуальные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция | |
| IL62152A0 (en) | Indane derivatives,pharmalceutical compositions and methods of preparation | |
| DK607783D0 (da) | Nitroaliphatiske forbindelser | |
| DE3477488D1 (en) | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
| KR830008675A (ko) | 항소화성 궤양제의 제조방법 | |
| ES8501763A1 (es) | "procedimiento para la fabricacion de derivados de la tetrahidro-5.6.7.7. 4h-tieno (3, 2-c) piridinona-2 | |
| JPS52113974A (en) | Synthesis of benzotriazole derivatives | |
| PT80791A (fr) | Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres | |
| JPS616079B2 (ko) | ||
| KR930012018A (ko) | 약제학적 조성물 | |
| KR840008588A (ko) | 경구투여용 정제의 제조방법 | |
| SE8601799D0 (sv) | (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydroindolo/2,3-a/quinolizine, process for its preparation and pharmaceutical compositions containing same | |
| KR850002478A (ko) | 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법 | |
| ES263931A1 (es) | Procedimiento de obtenciën de derivados de tiaxanteno | |
| KR910002786A (ko) | 아즈렌 유도체, 트롬복산 a₂ 및 프로스타글랜딘 엔도퍼옥사이드 수용체 길항제 및 그의 제법 | |
| JPS52113973A (en) | Synthesis of benzotriazole derivatives | |
| KR870001219A (ko) | 세프-3-엠-4-카르복실산 유도체의 제조방법 | |
| IL117289A (en) | Spectinomycin boron derivatives and stable high potency aqueous pharmaceutical compositions containing them | |
| JPS5640610A (en) | Remedy for hyperlipemia containing metal salt of monacolin k as the major component | |
| JPS53119822A (en) | Preparation of 2-dimethylaminoethylisothiocyanate | |
| KR910009662A (ko) | 피리딘-2,4- 및 2,5-디카복사미드, 이들의 제조방법 및 이들의 용도 |